^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    zelavespib intravenous (PU-H71 IV)

    i
    Associations
    News
    Trials
    Company:
    Memorial Sloan-Kettering Cancer Center, Samus Therap
    Drug class:
    HSP90 inhibitor
    Related drugs:
    Associations
    News
    Trials